Baidu
map
BMC COMPLEMENT MED 润色咨询

BMC Complementary Medicine and Therapies

出版年份：2020 年文章数：734 投稿命中率： 开通期刊会员，数据随心看

出版周期：C 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2023-11-06 147350dfm22暂无昵称 来自广东省

    偏重的研究方向：药学
    经验分享：10月16号提交技术审查，到现在都还没通过。。。。

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2023-03-02 ms1000000305223838 来自河北省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向：中医
    经验分享：这个期刊if到底是多少

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2024-05-24 ms9000001670056033 来自河北省

    复方因为有动物成分被拒？

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2021-06-15 12171fa9m59暂无昵称

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：干细胞;中药小分子
    经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF
    拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2024-04-06 ms9000001026547573 来自香港

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：补充医学;临床
    经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。
    第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。
    觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2021-11-03 ms3000000150745947

    好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2023-11-20 ms5000001496653792 来自天津

    审稿速度:2.0
    经验分享：发

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2023-08-16 ms8000001033052510 来自湖南省

    有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2023-08-16 ms8000001033052510 来自湖南省

    Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向：药学<br>经验分享：10月16号提交技术审查，到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：中医<br>经验分享：这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;中药小分子<br>经验分享：2020年12月22日投出，1月中旬才送外审，4月才回第一个审稿人的意见，5月拒稿。历时半年WTF<br>拒稿理由是，我的wb图是裁剪过的，他们需要完整没裁剪的！！！！印度编辑的要求！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：补充医学;临床<br>经验分享：第一篇是2022年3月投出去的，期间返修了2次，2023年1月接收的，审稿意见特别详细，但是内容很好，大概十几页，reply letter最后大概有接近30页，比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的，返修1次，2024年2月接收的，审稿意见也给的很好，总之就是慢认真的，我们也认真的回复了，很快就接收了。<br>觉得杂志主编的态度很好，认真找审稿人，也努力在推进了，质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪，为什么明明审稿人意见已经回来，然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享：发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志，审稿意见回来一个多月了，编辑部一直没有消息，是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了，编辑部一直没有通知，有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了，技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆)]
    2023-07-21 ms4000000353566827 来自重庆

    这个杂志太慢了，技术审查都要半个多月

    2

    展开2条回复
共59条页码: 1/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map